Dr. Krina Zondervan has spent three decades using genomics and epidemiology to expose the causes of endometriosis and pelvic ...

Artificial intelligence is rapidly becoming medicine’s most powerful microscope, revealing patterns in human DNA that were invisible to doctors and researchers only a few years ago. Instead of ...

Former Google and Reddit AI scientist builds tool to decode genetic clues standard medicine dismisses as 'normal' ...

Twenty-five years ago this week, President Bill Clinton stood before a podium in the East Room of the White House, and, in front of an all-star lineup of researchers and dignitaries, made a historic ...

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...

AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely a mystery.

Get the latest digital health news from MobiHealthNews daily and weekly delivered to your inbox.

Like many other Icelanders, neurologist Kari Stefansson can trace his lineage back to a single Viking, and that got him thinking about the genetic roots of disease. Stefansson, 58, had been a ...

A new genomic study provides a breakthrough in understanding cold tolerance in pomegranates, a major hurdle for cultivating prized soft-seeded varieties. Researchers have assembled a high-quality ...

This press release contains forward-looking statements related to 10x Genomics, Inc. within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the ...

In 2024, two scientists from Google DeepMind shared the Nobel Prize in chemistry for an artificial-intelligence program called AlphaFold2. For decades, scientists had struggled to understand how ...

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value ...